$CC Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of $0.21 up 23.53% YoY
• Reported revenue of $1.54B up 3.01% YoY
• Chemours expects 2026 Net Sales to grow approximately 2% over 2025 and Adjusted EBITDA between $775M and $800M; Q4 consolidated Adjusted EBITDA is expected to range between $160M and $185M.